• Accueil >
  • Publications >
  • Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

1 déc. 2019American Journal of Surgical Pathology

DOI : 10.1097/pas.0000000000001371

Auteurs

Charlotte S. Voskuilen, Htoo Zarni Oo, Vera Genitsch, Laura A. Smit, Alvaro Vidal, Manuel Meneses, Andrea Necchi, Maurizio Colecchia, Evanguelos Xylinas, Jacqueline Fontugne, Mathilde Sibony, Morgan Rouprêt, Louis Lenfant, Jean-François Côté, Lorenz Buser, Karim Saba, Marc A. Furrer, Michiel S. van der Heijden, Mads Daugaard, Peter C. Black, Bas W.G. van Rhijn, Kees Hendricksen, Cédric Poyet, Roland Seiler